SNOA vs SPGI · rev $19.5M vs P/E 27, rev $15.34B
Sonoma Pharmaceuticals Inc (SNOA) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
SNOA currently screens at market cap $4.9M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the SNOA and SPGI stock pages for the full models.
Not investment advice.